Abstract
Research question
Is overnight transportation of ovarian tissue before cryopreservation in a centralized
cryobank from the FertiPROTEKT network feasible?
Design
Data from 1810 women with cryopreserved ovarian tissue after overnight transportation
from December 2000 to December 2017 were analysed with a focus on transportation,
tissue activity parameters and pregnancy, and delivery rates after transplantation.
Results
A total of 92.4% of tissue samples arrived at ideal temperatures of 2–8°C, 0.4% were
transported at temperatures lower than ideal and 6.4% were transported at temperatures
that were too high, generally due to mishandling of the inlayed cool packs of the
transportation boxes. In 62 women, 78 tissue transplantations were carried out. A
subgroup of 30 women who underwent a single orthotopic transplantation with fulfilled
criteria of a complete follow-up after transplantation until the end of study, a premature
ovarian insufficiency after gonadotoxic therapy as well as the absence of pelvic radiation,
was further analysed. In this group, transplantations into a peritoneal pocket accounted
for 90%. Transplants were still active at 1 year and above after transplantation in
93.3%. Pregnancy and delivery rates were 46.7% and 43.3%, respectively, with one ongoing
pregnancy at the end of the study.
Conclusions
Overnight transportation for central cryobanking is a feasible concept that results
in high reproducible success rates through standardized professional tissue freezing
and storage.
KEYWORDS
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Reproductive BioMedicine OnlineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency.J. Assist. Reprod. Genet. 2016; 33: 1605-1614
- Efficacy of ovarian tissue cryopreservation in a major European center.J. Assist. Reprod. Genet. 2014; 31: 1003-1012
- Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation.Geburtshilfe Frauenheilkd. 2018; 78: 1-10https://doi.org/10.1055/a-0664-8619
- Organ donor management and procurement.(editors)in: Klein A.A. Lewish C.J. Madsen C.J. Organ Transplantation: A Clinical Guide. 53. 2011
- Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.Fertil. Steril. 2018; 109: 478-485
- Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center.Fertil. Steril. 2015; 103: 462-468
- Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation.Fertil. Steril. 2012; 97: 387-390
- Risk of transplanting malignant cells in cryopreserved ovarian tissue.Minerva. Ginecol. 2018 Apr 11; https://doi.org/10.23736/S0026-4784.18.04233-8
- Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue.Fertil. Steril. 2013; 99: 1514-1522
- Techniques for ovarian tissue transplantation and results.Minerva. Ginecol. 2018 Apr 11; https://doi.org/10.23736/S0026-4784.18.04228-4
- Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice.J. Assist. Reprod. Genet. 2015; 32: 1167-1170
- Ovarian tissue freezing: current status.Curr. Opin. Obstet. Gynecol. 2015; 27: 222-230
- Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.Lancet. 2004; 364 (Erratum in: Lancet. 2004;364(9450):2020): 1405-1410 .
- Ovarian tissue transport to expand access to fertility preservation: from animals to clinical practice.Reproduction. 2016; 152: 201-210
- Ex-vivo oocyte retrieval for fertility preservation.Fertil. Steril. 2011; 95 (1787.e15-7)
- Use of the new preservation solution Custodiol-N supplemented with dextran for hypothermic machine perfusion of the kidney.Cryobiology. 2013; 66: 131-135
- Restoration of fertility to oophorectomized sheep by ovarian autografts stored at −196° C.Hum. Reprod. 1994; 9: 597-603
- Organ Preservation: Current Concepts and New Strategies for the Next Decade.Transfus. Med. Hemother. 2011; 38: 125-142
- Isolated primate primordial follicles require a rigid physical environment to survive and grow in vitro.Hum. Reprod. 2012; 27: 1801-1810
- Increasing follicular and stromal cell proliferation in cryopreserved human ovarian tissue after long-term precooling prior to freezing: in vitro versus chorioallantoic membrane (CAM) xenotransplantation.Cell Transplant. 2013; 22: 2053-2061
- Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing.Geburtshilfe Frauenheilkd. 2012; 72: 927-932
- Comparison of in vitro- and chorioallantoic membrane (CAM)-culture systems for cryopreserved medulla-contained human ovarian tissue.PLoS One. 2012; 7: e32549
- Effect of long-term exposure at suprazero temperatures on activity and viability of human ovarian cortex.Fertil. Steril. 2009 Apr; 91: 1556-1559
- Cryopreservation of human ovarian tissue: comparison of rapid and conventional freezing.Cryobiology. 2007; 55: 261-268
- Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases.Hum Reprod. 2017; 32: 1046-1054
- 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children.J. Assist. Reprod. Genet. 2017; 34: 325-336
- Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark.Hum. Reprod. 2015; 30: 2838-2845
- Comprehensive Review on Custodiol-N (HTK-N) and its Molecular Side of Action for Organ Preservation.Curr. Pharm. Biotechnol. 2017; 18: 1237-1248
- Investigation of in vitro parameters and fertility of mouse ovary after storage at an optimal temperature and duration for transportation.Hum. Reprod. 2016; 31: 774-781
- Alginate encapsulation supports the growth and differentiation of human primordial follicles within ovarian cortical tissue.J. Assist. Reprod. Genet. 2014; 31: 1013-1028
- Preservation solutions for liver transplantation in adults: celsior versus custodiol: a systematic review and meta-analysis with an indirect comparison of randomized trials.Transplant. Proc. 2013; 45: 25-32
- Ovarian primordial and primary follicle density in 1002 ovarian tissue and AMH concentrations in 824 serum samples for a better reflection of the ovarian reserve. ESHRE ABSTRACT BOOK (SUPPL).Hum. Reproduction. 2018; 33(suppl 1): i386
- Chapter 15 Development of a Nationwide Network for Ovarian Tissue Cryopreservation.Methods Mol. Biol. 2017; 1568: 205-220
- The impact of culture conditions on early follicle recruitment and growth from human ovarian cortex biopsies in vitro.Fertil. Steril. 2013 Aug; 100: 483-491
- Short-term storage of canine preantral ovarian follicles using a powdered coconut water (ACP)-based medium.Theriogenology. 2010; 74: 146-152
- Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury.J. Thorac. Cardiovasc. Surg. 2010; 139: 1048-1056
- Effects of lowered temperatures and media on short-term preservation of zebu (Bos indicus) preantral ovarian follicles.Theriogenology. 2004; 61: 461-472
- Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria.Fertil. Steril. 2016; 106: 467-474
- Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis.Reprod. Sci. 2017; 24: 1111-1120
- Cryopreservation of in vitro matured oocytes after ex vivo oocyte retrieval from gynecologic cancer patients undergoing radical surgery.Clin. Exp. Reprod. Med. 2016; 43: 119-125
- Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique.Reprod. Biomed. Online. 2011; 22: 162-171
- Effect of coconut water and Braun-Collins solutions at different temperatures and incubation times on the morphology of goat preantral follicles preserved in vitro.Theriogenology. 2000; 54: 809-822
- Effects of in-vivo and in-vitro environments on the metabolism of the cumulus-oocyte complex and its influence on oocyte developmental capacity.Hum. Reprod. Update. 2003; 9: 35-48
- Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63.Nat. Struct. Mol. Biol. 2018 Mar; 25: 261-269
- Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.Hum. Reprod. 2016; 31: 2031-2041
- Perspectives on abdominal organ preservation solutions: a comparative literature review.Prog. Transplant. 2013; 23: 383-391
- Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques.Arch. Gynecol. Obstet. 2018; 297: 257-267
- Is Ovarian Tissue Cryopreservation and Transplantation Still Experimental? It Is a Matter of Female Age and Type of Cancer.J. Clin. Oncol. 2018 Oct 5; (JCO1800425)https://doi.org/10.1200/JCO.18.00425
- Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women.Reprod. Biomed. Online. 2015; 31: 605-612
- What is new in 2017? Update on fertility preservation in cancer patients.Minerva. Endocrinol. 2017; 42: 331-339
Biography

Key message
Ovarian tissue cryopreservation is gaining more acceptance in clinical practice as an established option for fertility protection. Nevertheless, as the techniques require high expertise for reproducible success rates, the concept of centralized cryobanking can be carried over by fertility preservation networks to allow optimal tissue freezing and storage for everyone.
Article info
Publication history
Published online: January 18, 2019
Accepted:
January 3,
2019
Received in revised form:
December 21,
2018
Received:
June 18,
2018
Declaration: One of the authors (MM) is CEO of a consultancy company that provides consultancy service for establishing ovarian cryobanking facilities. The other authors report no commercial or financial conflicts of interest.Identification
Copyright
© 2019 Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.